Tawakalitu O. Oseni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tawakalitu O. Oseni has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Biqi Zhang
Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA
3 shared publicationsDavid C. Chang
Department of Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
2 shared publicationsKevin S. Hughes
Department of Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
2 shared publicationsMichele A. Gadd
Department of Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
2 shared publicationsSuzanne B. Coopey
Department of Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
2 shared publicationsAmanda B. Francescatti
American College of Surgeons Cancer Programs, Chicago, IL, USA
1 shared publication
Latest Publications
- 25 May 2023
- Published by Elsevier in The American Journal of Surgery
- Vol. 226 (4) , 432-437
Time to surgery: A health equity metric in breast cancer patients
- 25 May 2023
- Published by Elsevier in The American Journal of Surgery
- Vol. 226 (4) , 432-437
Time to surgery: A health equity metric in breast cancer patients
- 22 January 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 224 (1) , 259-263
Diversity efforts in surgery: Are we there yet?
- 22 January 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 224 (1) , 259-263
Diversity efforts in surgery: Are we there yet?
- 9 January 2021
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (9) , 4995-5004
Uptake of Breast Cancer Clinical Trials at Minority Serving Cancer Centers
Most minorities receive cancer care at minority-serving hospitals (MSHs) that have been associated with disparate treatment between Black and White patient
- 9 January 2021
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (9) , 4995-5004
Uptake of Breast Cancer Clinical Trials at Minority Serving Cancer Centers
Most minorities receive cancer care at minority-serving hospitals (MSHs) that have been associated with disparate treatment between Black and White patient
- 1 August 2020
- Published by Elsevier in European Journal of Radiology
- Vol. 129, 109130
Pre-operative MRI in patients with ductal carcinoma in situ: Is MRI useful for identifying additional disease?
- 1 August 2020
- Published by Elsevier in European Journal of Radiology
- Vol. 129, 109130
Pre-operative MRI in patients with ductal carcinoma in situ: Is MRI useful for identifying additional disease?
- 31 October 2019
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 26 (S3) , 834-835
ASO Author Reflections: Contralateral Prophylactic Mastectomy—Moving Beyond Sociodemographic Factors
- 31 October 2019
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 26 (S3) , 834-835
ASO Author Reflections: Contralateral Prophylactic Mastectomy—Moving Beyond Sociodemographic Factors
- 19 July 2019
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 26 (12) , 3863-3873
Trends in Unilateral and Contralateral Prophylactic Mastectomy Use in Ductal Carcinoma In Situ of the Breast: Patterns and Predictors
Increased use of contralateral prophylactic mastectomy (CPM) as treatment for ductal carcinoma in situ (DCIS) in the US was first noted in the early 2000s. Optimization of treatment guidelines for DCIS requires an understanding of current surgical treatment trends, particularly as they may differ by patient sociodemographic and community resource factors. The aim of this study was to evaluate surgical treatment trends among US women with DCIS and to assess the impact of sociodemographic and community resource factors on surgical treatment choice. The Surveillance, Epidemiology, and End Results dataset was queried for women aged 40 years and older who were diagnosed with unilateral DCIS between 2000 and 2014. Annual mastectomy rates were compared over time by age and race/ethnicity. Multivariable logistic regressions were performed to identify predictors of mastectomy use, with patient sociodemographics, tumor characteristics, and community resource factors (i.e. plastic surgeon density) as covariates. A total of 130,731 women with DCIS met the inclusion criteria. Overall mastectomy rates remained relatively unchanged over the study period (25-30%). CPM use increased for all age and race/ethnic groups, with the greatest increase exhibited by women aged 40-49 years [relative to 2000; 2014 odds ratio (OR) 10.6]. With respect to community resource factors, CPM use, as opposed to unilateral mastectomy, was associated with counties of higher education level (OR 1.52), higher income level (OR 1.22), and lower plastic surgeon density (OR 1.26). While the popularity of mastectomy in the management of DCIS has remained relatively unchanged since the turn of the century, the use of CPM has risen substantially. Younger women with DCIS have seen the greatest increase in CPM use, a choice that remains influenced by race/ethnicity as well as income, education, and health resource availability. Until clinical risk stratifiers of DCIS are identified, the surgical decision-making paradigm must be improved so that treatment choice remains sensitive to cultural differences but becomes independent of income, education, and health resource availability.
- 19 July 2019
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 26 (12) , 3863-3873
Trends in Unilateral and Contralateral Prophylactic Mastectomy Use in Ductal Carcinoma In Situ of the Breast: Patterns and Predictors
Increased use of contralateral prophylactic mastectomy (CPM) as treatment for ductal carcinoma in situ (DCIS) in the US was first noted in the early 2000s. Optimization of treatment guidelines for DCIS requires an understanding of current surgical treatment trends, particularly as they may differ by patient sociodemographic and community resource factors. The aim of this study was to evaluate surgical treatment trends among US women with DCIS and to assess the impact of sociodemographic and community resource factors on surgical treatment choice. The Surveillance, Epidemiology, and End Results dataset was queried for women aged 40 years and older who were diagnosed with unilateral DCIS between 2000 and 2014. Annual mastectomy rates were compared over time by age and race/ethnicity. Multivariable logistic regressions were performed to identify predictors of mastectomy use, with patient sociodemographics, tumor characteristics, and community resource factors (i.e. plastic surgeon density) as covariates. A total of 130,731 women with DCIS met the inclusion criteria. Overall mastectomy rates remained relatively unchanged over the study period (25-30%). CPM use increased for all age and race/ethnic groups, with the greatest increase exhibited by women aged 40-49 years [relative to 2000; 2014 odds ratio (OR) 10.6]. With respect to community resource factors, CPM use, as opposed to unilateral mastectomy, was associated with counties of higher education level (OR 1.52), higher income level (OR 1.22), and lower plastic surgeon density (OR 1.26). While the popularity of mastectomy in the management of DCIS has remained relatively unchanged since the turn of the century, the use of CPM has risen substantially. Younger women with DCIS have seen the greatest increase in CPM use, a choice that remains influenced by race/ethnicity as well as income, education, and health resource availability. Until clinical risk stratifiers of DCIS are identified, the surgical decision-making paradigm must be improved so that treatment choice remains sensitive to cultural differences but becomes independent of income, education, and health resource availability.
- 1 June 2019
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 228 (6) , 932-939
Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women
The rising incidence of ductal carcinoma in situ (DCIS) since the widespread enactment of mammography screening has been well documented. Patterns in DCIS incidence among women of various ages and across different racial and ethnic groups have not been well described. The Surveillance, Epidemiology, and End Results public-use data set was queried for all women aged 40 years and older diagnosed with DCIS between 1990 and 2014. Annual age-adjusted incidence rates were compared among white, black, Hispanic, and Asian-Pacific Islander women. Additionally, using mammography screening data obtained from the CDC, patterns in mammography screening over time and as they relate to DCIS incidence rates by race and ethnicity were evaluated. We identified 200,400 women aged 40 years or older with DCIS. Between 1998 and 2014, a period that saw flux in national breast screening guidelines, DCIS incidence rates increased in blacks, Hispanics, and Asian-Pacific Islanders, but remained relatively unchanged in whites (increase in number of DCIS diagnoses per 100,000 individuals in the population per year among blacks +0.66/p < 0.01, Hispanics +3.0/p < 0.01, Asian-Pacific Islanders +0.53/p < 0.01, and whites +0.07/p = 0.21). After accounting for age, year of diagnosis, and mammography screening rates, DCIS incidence was found to be similar between white and black women (0.8 fewer diagnoses per 100,000 individuals compared with whites; p = 0.36) but lower for Hispanic women (9.7 fewer diagnoses per 100,000 individuals compared with whites; p < 0.01). The DCIS incidence rates are influenced substantially by breast cancer mammography screening patterns. However, differences exist by race and ethnicity and are not fully explained by screening mammography trends alone. Consideration should be given to including race and ethnicity in determining optimal breast screening guidelines.
- 1 June 2019
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 228 (6) , 932-939
Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women
The rising incidence of ductal carcinoma in situ (DCIS) since the widespread enactment of mammography screening has been well documented. Patterns in DCIS incidence among women of various ages and across different racial and ethnic groups have not been well described. The Surveillance, Epidemiology, and End Results public-use data set was queried for all women aged 40 years and older diagnosed with DCIS between 1990 and 2014. Annual age-adjusted incidence rates were compared among white, black, Hispanic, and Asian-Pacific Islander women. Additionally, using mammography screening data obtained from the CDC, patterns in mammography screening over time and as they relate to DCIS incidence rates by race and ethnicity were evaluated. We identified 200,400 women aged 40 years or older with DCIS. Between 1998 and 2014, a period that saw flux in national breast screening guidelines, DCIS incidence rates increased in blacks, Hispanics, and Asian-Pacific Islanders, but remained relatively unchanged in whites (increase in number of DCIS diagnoses per 100,000 individuals in the population per year among blacks +0.66/p < 0.01, Hispanics +3.0/p < 0.01, Asian-Pacific Islanders +0.53/p < 0.01, and whites +0.07/p = 0.21). After accounting for age, year of diagnosis, and mammography screening rates, DCIS incidence was found to be similar between white and black women (0.8 fewer diagnoses per 100,000 individuals compared with whites; p = 0.36) but lower for Hispanic women (9.7 fewer diagnoses per 100,000 individuals compared with whites; p < 0.01). The DCIS incidence rates are influenced substantially by breast cancer mammography screening patterns. However, differences exist by race and ethnicity and are not fully explained by screening mammography trends alone. Consideration should be given to including race and ethnicity in determining optimal breast screening guidelines.